Search results
Showing 2371 to 2385 of 9128 results
In development Reference number: GID-QS10113 Expected publication date: TBC
Awaiting development Reference number: GID-QS10146 Expected publication date: TBC
In development Reference number: GID-QS10177 Expected publication date: TBC
Naxitamab with GM-CSF for treating relapsed or refractory high-risk neuroblastoma [ID3769]
Awaiting development Reference number: GID-TA10638 Expected publication date: TBC
Vosoritide for treating achondroplasia in children and young people under 18 years [ID3807]
Awaiting development Reference number: GID-TA10700 Expected publication date: TBC
Bupivacaine–meloxicam for treating postoperative pain [ID2728]
Awaiting development Reference number: GID-TA10716 Expected publication date: TBC
Vulnerable populations: strategies for tackling inequalities
Awaiting development Reference number: GID-QS10124 Expected publication date: TBC
Tasimelteon for treating sleep disturbance associated with Smith-Magenis syndrome [TSID12191]
Awaiting development Reference number: GID-TA11746 Expected publication date: TBC
Icotrokinra for treating moderate to severe plaque psoriasis in people 12 years and over [ID6579]
In development Reference number: GID-TA11780 Expected publication date: TBC
Zasocitinib for treating moderate to severe plaque psoriasis [ID6700]
Awaiting development Reference number: GID-TA11926 Expected publication date: TBC
Awaiting development Reference number: GID-HTG10389 Expected publication date: TBC
Edaravone for treating amyotrophic lateral sclerosis [TSID11869]
Awaiting development Reference number: GID-TA11362 Expected publication date: TBC
Awaiting development Reference number: GID-TA11527 Expected publication date: TBC
Awaiting development Reference number: GID-TA11842 Expected publication date: TBC
Vimseltinib for treating tenosynovial giant cell tumours when surgery is unsuitable [ID6736]
Awaiting development Reference number: GID-TA11964 Expected publication date: TBC